Detalhe da pesquisa
1.
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
BMC Cancer
; 22(1): 1013, 2022 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153475
2.
Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B-cell lymphoma.
Cancer
; 127(21): 3991-3997, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289094
3.
Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type.
Br J Haematol
; 196(4): e30-e33, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642938
4.
Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
Am J Hematol
; 91(4): 371-8, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26749142
5.
Late Psychiatric and Neurocognitive Effects of Chimeric Antigen Receptor T Cell Therapy Warrant Further Investigation.
Biol Blood Marrow Transplant
; 26(1): e3-e4, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740291
6.
Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-cell nHL Treated with CAR-T.
Blood Adv
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531057
7.
Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL.
Blood Adv
; 7(12): 2657-2669, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094847
8.
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis.
Clin Cancer Res
; 29(13): 2375-2384, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036505
9.
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
J Hematol Oncol
; 15(1): 96, 2022 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842643
10.
A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma.
Onco Targets Ther
; 14: 2185-2201, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33814917
11.
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib.
Exp Hematol
; 97: 57-65.e5, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617893
12.
Improving Splenomegaly Segmentation by Learning from Heterogeneous Multi-Source Labels.
Proc SPIE Int Soc Opt Eng
; 109492019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762532
13.
Acceleration of spleen segmentation with end-to-end deep learning method and automated pipeline.
Comput Biol Med
; 107: 109-117, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30798219
14.
Splenomegaly Segmentation on Multi-Modal MRI Using Deep Convolutional Networks.
IEEE Trans Med Imaging
; 38(5): 1185-1196, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30442602
15.
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.
Blood Adv
; 8(10): 2327-2331, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498727
16.
Revisiting the role of autologous stem cell transplant in relapsed/ refractory aggressive B cell lymphoma.
Transplant Cell Ther
; 29(8): 480-481, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37517845
17.
SynSeg-Net: Synthetic Segmentation Without Target Modality Ground Truth.
IEEE Trans Med Imaging
; 2018 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334788
18.
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.
Leuk Res
; 65: 67-73, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29310020
19.
Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
Blood Adv
; 7(1): 88-91, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269847
20.
Therapy for Chronic Myelomonocytic Leukemia in a New Era.
Curr Hematol Malig Rep
; 12(5): 468-477, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28983777